Efficacy of cell reprogramming using 3D spheroid model
InSphero presents the 3D InSight™ Oncology Platform to assess the efficacy of tumor-dendritic cell reprogramming
Stay updated with breaking news from Cell Reprogramming. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
InSphero presents the 3D InSight™ Oncology Platform to assess the efficacy of tumor-dendritic cell reprogramming
As of spring 2023, NASA has invested greater than $60M in more than twenty In Space Production Applications (InSPA) awards to U.S. entities seeking to
The widespread Transfection Technologies Market report presents crucial information about the elements that are impacting and driving the sales of the Transfection Technologies market. In this market report, a methodical SWOT analysis & investment analysis is performed which forecasts forthcoming opportunities for t...
EQS-News: Enlivex Therapeutics, Ltd. First Patients Dosed in Phase I/II Trial of Enlivex’s Off-the-Shelf Cell Therapy Candidate, AllocetraTM 02.12.2022 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. On November 13, Enlivex (NASDAQ: ENLV) announced that th...
Five area businesses have received grants to help them commercialize their products through SBIR Advance’s latest funding round.